Perspectives and state-of-the-art use of metal-derived, porous nanomaterials and metallo-drugs for biomedical applications
- PMID: 41280486
- PMCID: PMC12634973
- DOI: 10.1007/s13205-025-04540-x
Perspectives and state-of-the-art use of metal-derived, porous nanomaterials and metallo-drugs for biomedical applications
Abstract
Due to a combination of genetic, environmental, and behavioral factors, the number of infectious and non-infectious diseases affecting humans has been rising. Many illnesses are in the forefront of research and development such as neoplasms of different forms, chronic conditions related to inflammation and lifestyle (e.g., cancer, diabetes mellitus, Alzheimer's and Parkinson's diseases) and infectious diseases that are difficult to treat (e.g., due to drug resistance). Due to current challenges in diagnosis and treatment of diseases and health conditions, the field of nanotechnology has witnessed numerous advancements. In particular, metal-based, porous nanomaterials and metallo-drugs have gained attention due to their ability to be used for various diagnostic and therapeutic applications. These systems exhibit excellent physicochemical properties, with amenable functionalization and varying optical, scattering and electronic properties, enabling for both imaging and therapy of diseases (i.e., theranostics), involving techniques such as photoacoustic imaging, magnetic resonance imaging (MRI), computed tomography (CT), photothermal therapy (PTT), photodynamic therapy (PDT) and radiotherapy. This review discusses the important aspects of metal nanoparticles, porous-based materials and metallo-drugs for biomedical applications, exploring their physical and chemical characteristics, cellular/molecular processes and biopotencies that make them effective in treating a variety of illnesses or diseases.
Keywords: Biomedical applications; Metal nanoparticles; Metallo-drugs; Porous-based materials.
© King Abdulaziz City for Science and Technology 2025. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Conflict of interest statement
Conflict of interestThere are no conflicts of interest relating to this article.
References
-
- Abdolmaleki S, Khaksar S, Aliabadi A et al (2023) Cytotoxicity and mechanism of action of metal complexes: an overview. Toxicology 492:153516 - PubMed
-
- Adhikari S, Nath P, Das A et al (2024) A review on metal complexes and its anti-cancer activities: recent updates from in vivo studies. Biomed Pharmacother 171:116211 - PubMed
-
- Agarwal H, Nakara A, Shanmugam VK (2019) Anti-inflammatory mechanism of various metal and metal oxide nanoparticles synthesized using plant extracts: a review. Biomed Pharmacother 109:2561–2572 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
